RecruitingPhase 2Phase 3NCT03916978

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Investigating Reactivation of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Menopausal Women


Sponsor

Genesis Athens Clinic

Enrollment

100 participants

Start Date

May 21, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 55 Years

Inclusion Criteria4

  • Age between 45-55 years old
  • Amenorrhea for at least 12 months
  • Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
  • Willing to comply with study requirements

Exclusion Criteria15

  • Any pathological disorder related to reproductive system anatomy
  • Previous POI diagnosis
  • Abnormal karyotype
  • Endometriosis
  • Adenomyosis
  • Fibroids and adhesions
  • Infections in reproductive system
  • Current or previous diagnosis of reproductive system cancer
  • History of familiar cancer in reproductive system
  • Severe male factor infertility
  • Prior referral for PGT
  • Ovarian inaccessibility
  • Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
  • BMI>30 kg/m2 or BMI<18.5 kg/m2
  • Systematic autoimmune disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAutologous PRP intra ovarian infusion

Autologous PRP intra ovarian infusion

BIOLOGICALAutologous PFP intra ovarian infusion

Autologous PFP intra ovarian infusion


Locations(1)

Genesis AC

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03916978


Related Trials